Risk-based management of prostate cancer
- PMID: 21751910
- DOI: 10.1056/NEJMe1103829
Risk-based management of prostate cancer
Comment on
-
Radiotherapy and short-term androgen deprivation for localized prostate cancer.N Engl J Med. 2011 Jul 14;365(2):107-18. doi: 10.1056/NEJMoa1012348. N Engl J Med. 2011. PMID: 21751904 Clinical Trial.
Similar articles
-
[High risk prostate cancer results of one year RT-HT].Prog Urol. 2005 Dec;15(6 Suppl 1):1256-61. Prog Urol. 2005. PMID: 16734214 Clinical Trial. French. No abstract available.
-
Long-term outcomes of 60 Gy conventional radiotherapy combined with androgen deprivation for localized or locally advanced prostate cancer.Jpn J Clin Oncol. 2005 Nov;35(11):655-9. doi: 10.1093/jjco/hyi174. Epub 2005 Nov 7. Jpn J Clin Oncol. 2005. PMID: 16275680
-
Risk of death from prostate cancer after brachytherapy alone or with radiation, androgen suppression therapy, or both in men with high-risk disease.J Clin Oncol. 2009 Aug 20;27(24):3923-8. doi: 10.1200/JCO.2008.20.3992. Epub 2009 Jul 13. J Clin Oncol. 2009. PMID: 19597029
-
[Combined radiotherapy and hormone therapy in non-metastatic adenocarcinoma of prostate].Bull Cancer. 2009 Mar;96(3):261-70. doi: 10.1684/bdc.2009.0832. Bull Cancer. 2009. PMID: 19318304 Review. French.
-
[Combination of external irradiation and androgen suppression for prostate cancer: facts and questions].Cancer Radiother. 2010 Oct;14(6-7):510-4. doi: 10.1016/j.canrad.2010.07.226. Epub 2010 Aug 21. Cancer Radiother. 2010. PMID: 20728391 Review. French.
Cited by
-
Imaging assessment of prostate cancer recurrence: advances in detection of local and systemic relapse.Abdom Radiol (NY). 2024 Sep 10. doi: 10.1007/s00261-024-04412-7. Online ahead of print. Abdom Radiol (NY). 2024. PMID: 39254707 Review.
-
Prostate cancer risk stratification via eNose urine odor analysis: a preliminary report.Front Oncol. 2024 Mar 5;14:1339796. doi: 10.3389/fonc.2024.1339796. eCollection 2024. Front Oncol. 2024. PMID: 38505583 Free PMC article.
-
Diagnostic value of [99mTc]Tc-PSMA-I&S-SPECT/CT for the primary staging and restaging of prostate cancer.Ther Adv Med Oncol. 2024 Jan 18;16:17588359231221342. doi: 10.1177/17588359231221342. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 38249326 Free PMC article.
-
Genetically adjusted PSA levels for prostate cancer screening.Nat Med. 2023 Jun;29(6):1412-1423. doi: 10.1038/s41591-023-02277-9. Epub 2023 Jun 1. Nat Med. 2023. PMID: 37264206 Free PMC article.
-
Observation, Radiotherapy, or Radical Prostatectomy for Localized Prostate Cancer: Survival Analysis in the United States.World J Mens Health. 2023 Oct;41(4):940-950. doi: 10.5534/wjmh.220151. Epub 2023 Mar 15. World J Mens Health. 2023. PMID: 37118954 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical